Our panel conveners have identified the following readings as useful background material to their panel.
Panel 1. Closing the Gap in Health Inequalities – is Genomics Part of the Solution?
D. Gurwitz , Zika E.,Hopkins M.M. ,Gaisser S. , Ibarreta D. Pharmacogenetics in Europe: Barriers and Opportunities Public Health Genomics 2009;12:134–141.
M. M. Hopkins, Martin, Paul A, Nightingale, Paul, Kraft, Alison and Mahdi, Surya (2007) The myth of the biotech revolution: an assessment of technological, clinical and organisational change. Research Policy, 36 (4). pp. 566-589.
T. Pang and D.J. Weatherall (2012) Genomics and World Health: a decade on. May 19, 2012; 379: 1853-1854.
Panel 2: Personal Genome Project (PGP)-UK and Genetic Privacy
Dickenson, Donna (2013) Me Medicine vs. We Medicine: Reclaiming Biotechnology for the Common Good. New York: Columbia University Press.
Tutton, Richard & Oonagh Corrigan (2004) Genetic Databases: Socio-ethical issues in the collection and use of DNA. New York: Routledge.
Wallace, Helen (2014) GeneWatch UK response to the Nuffield Council on Bioethics’ consultation on the linking and use of biological and health data. Available at:
Panel 3. Manipulated Microbes: Genetics, Genomics and Global Health Security
Elbe, Stefan and Anne Roemer-Mahler. 2014. Pharmaceuticals and Security: Strengthening Industry Engagement. Summary Report. /webteam/gateway/file.php?name=erc-report.pdf&site=346
Herfst, Sander, Eefje Schrauwen, Artin Linster, Chutinimitkul et al. 2013. Airborne transmission of Influenza A/H5N1 virus between ferrets. Science, 336;1534-1541.
Imai, Masaki, Tokiko Watanabe, Masato Hatta, Subash Das et al. 2013. Experimental adaptation of an influenza H5HA reassortant H5 HA/H1N1 virus in ferrets. Nature, 486:420-428.
Lipsitch M and Galvani AP. 2014. Ethical Alternatives to Experiments with Novel Potential Pandemic Pathogens. PLoS Med 11(5): e1001646. DOI:10.1371/journal.pmed.1001646.
Panel 4. Emerging Molecular Diagnostics – What are the Challenges to Widespread Implementation?
M. M. Hopkins, Ibarreta, Dolores, Gaisser, Sibylle, Enzing, Christien M, Nightingale, Paul et al, (2006) Nature Biotechnology, 24 (4). pp. 403-410.
R. W. Peeling and D. Mabey. Point-of-care tests for diagnosing infections in the developing world. Clin. Microbiol. Infec. 16: 1062–106
Cathy A. Petti, Christopher R. Polage, Thomas C. Quinn, Allan R. Ronald, and Merle A. Sande. Laboratory Medicine in Africa: A Barrier to Effective. CID 2006:42 (1 February)
Panel 5. Genetic Discrimination and Genetic Identities in Non-Western Societies
Berthier-Foglar, Sheila Collingwood-Whittick and Sandrine Tolazzi (2012) Biomapping Indigenous Peoples. Towards and understanding of the issues. Amsterdam & New York: Rodolpi
Gibbon, Sarah and Novas, Carlos (eds). 2008. Biosocialities, Identity and the Social Sciences London, Routledge
Sleeboom-Faulkner, M. (ed.) (2010) Frameworks of Choice: Predictive & Genetic Testing in Asia, Amsterdam: University of Amsterdam Press.
Panel 6. Bioinformation Economies: Benefits and Insecurities for Genomic Global Health
Bronwyn Parry. 2004. Trading the Genome: Investigating the Commodification of Bio-Information. Columbia University Press.
Harvey, M., McMeekin, A. (2009). Public or private economies of knowledge: The economics of diffusion and appropriation of bioinformatics tools. International Journal of the Commons, North America, vol 4, At: <http://www.thecommonsjournal.org/index.php/ijc/article/view/144/148
Hinterberger, Amy. 2012. Investing in Life, Investing in Difference: Nations, Populations and Genomes. Theory, Culture and Society, 29(3): 72–93.
Leonelli S. 2014. What Difference Does Quantity Make? On the Epistemology of Big Data Biology, Big Data & Society 1, 1: doi: 10.1177/2053951714534395 April-June 2014
Lewis J. and Bartlett A. (2013) Inscribing a discipline: tensions in the field of Bioinformatics. New Genetics and Society, Vol. 32, No. 3, 243–263.